In the production of sterile preparations, a filling isolator serves as the core equipment for maintaining a Grade A aseptic barrier. While hardware performance is the foundation, a comprehensive, traceable, and audit-ready GMP validation system is what truly ensures product sterility. AN establishes a full-lifecycle validation closed loop—extending from Design Qualification (DQ) to ongoing re-qualification—with a rigorous focus on two critical parameters: leak rate and sterilization validation. By precisely addressing key industry compliance challenges, AN empowers pharmaceutical companies to achieve efficient equipment compliance and navigate unannounced regulatory inspections with ease.
In the current landscape of increasingly routine unannounced inspections within the pharmaceutical industry, deficiencies in isolator validation have emerged as a frequent risk point for aseptic manufacturing facilities. For many companies, the fundamental issue is not necessarily outdated hardware, but rather failures to meet leakage rate standards, incomplete sterilization validation, and a lack of quantitative data to support key performance indicators. These shortcomings lead to gaps in the validation chain and, ultimately, failure to pass regulatory inspections. A filling isolator cannot be put into operation immediately upon installation; it must undergo a comprehensive validation lifecycle—encompassing DQ, FAT, SAT, IQ, OQ, and PQ. This process must prioritize the verification of critical parameters such as leakage rates and sterilization efficacy. By covering all dimensions—including the equipment itself, sterilization systems, the environment, and process simulations—and compiling a complete, quantitatively-supported validation dossier, a facility can ensure the isolator is ready for commercial production.
I. Design Qualification (DQ)
Anchor core metrics and lock in compliance standards at the source.
Validation begins with design, and Design Qualification (DQ) serves as the essential foundational prerequisite for the entire validation process. Based on the User Requirements Specification (URS)—and incorporating the GMP Annex on sterile products as well as industry-specific standards for isolators—a risk assessment is conducted, focusing on two core dimensions: leak control and VHP sterilization performance. This process defines critical equipment design parameters, ensuring that key performance indicators are met and preventing potential non-compliance issues from the very outset.
During the DQ (Design Qualification) phase, AN focuses on solidifying the design standards for two key core metrics.
Q: Design Thresholds for Leakage Rates
A: Designed in strict accordance with the ISO 13408 standard, the system establishes specific allowable leakage values for the enclosure as a whole, as well as for glove ports, RTP (Rapid Transfer Port) interfaces, and piping connections, thereby eliminating structural leakage defects.
Q: Design Standards for Sterilization Systems
A: The design must account for the complex operating conditions of the filling station by defining the VHP (Vaporized Hydrogen Peroxide) concentration range, cycle duration, temperature and humidity parameters, and the ability to reach and sterilize "dead zones" (hard-to-access areas). This ensures that subsequent sterilization validation is both feasible and capable of meeting the required standards.
Comprehensive design blueprints, a list of core components, and a risk analysis report are provided, enabling the early identification of intervention points during the filling process, potential "dead zones" in material transfer, and vulnerable sealing points. This proactive approach helps avoid the need for rework during the final verification of key performance indicators, ensuring that the equipment design is fully aligned with regulatory requirements, production processes, and essential performance specifications.
II. Factory Acceptance Testing (FAT)
Site Acceptance Testing (SAT): Dual-verification of core hardware performance
FAT and SAT serve as essential pre-validation checkpoints, acting as filters to detect and intercept hardware defects related to containment (leakage) and sterilization—both at the manufacturing stage and upon arrival at the site.
Key FAT and SAT Metrics
Filling Isolator
01: Factory Acceptance Testing (FAT)
Once the equipment has been fully assembled at the manufacturer’s facility, key procedures are conducted, including preliminary leak testing of the entire unit, simulated VHP (Vaporized Hydrogen Peroxide) sterilization cycle testing, and integrity testing of the glove system. Under simulated full-load production conditions, the sealing performance of the chamber, the uniformity of VHP distribution (atomization) during sterilization, and the accuracy of sensors are verified. Furthermore, the compliance of core components is audited. These steps are designed to proactively identify hardware issues—such as leaks or instability in the sterilization cycle—ensuring that no equipment leaves the factory with critical performance defects.
02: Site Acceptance Testing (SAT)
Following the delivery and installation of the equipment, key performance indicators are re-evaluated. This involves verifying the integrity of the chamber’s sealing structure, the layout of the VHP (Vaporized Hydrogen Peroxide) piping, and the precision with which gloves and sealing components are installed—ensuring there are no potential leak points resulting from the installation process. Furthermore, the compatibility of the sterilization system with facility utilities is confirmed. These steps establish a robust hardware foundation for subsequent high-precision leak rate testing and sterilization validation.
III. Installation Qualification (IQ)
Verify the compliance of hardware installation against key specifications.
Core objectives of IQ (Installation Qualification): To confirm that the equipment installation process and the selection of components fully meet the fundamental requirements for leakage control and sterilization compliance, while ensuring that the hardware installation is both traceable and verifiable.
✅ Verification of the Sealing System (Foundation for Leakage Rate Control): Conduct a comprehensive inspection of all sealing points—including chamber welds, flange seals, glove/sleeve ports, transfer hatch gaskets, and pipe connections—to ensure there is no deformation, looseness, or damage. Verify the levelness of the chamber installation to prevent uneven stress that could lead to latent leaks, thereby ensuring that conditions for subsequent leakage rate testing are compliant.
✅ Verification of the Sterilization System (Foundation for Sterilization Validation): Check the proper installation of the VHP (Vaporized Hydrogen Peroxide) generator, atomization piping, circulation air vents, and exhaust filtration systems. Confirm that there are no blockages in the piping or obstructions at the air vents, and ensure that designated locations for Biological Indicator (BI) placement are correctly established. Verify that sensors for temperature, humidity, and hydrogen peroxide concentration are properly calibrated to ensure the accurate collection of parameters during the sterilization cycle.
✅ Documentation Archiving: Collect certificates of conformity for core components, sensor calibration certificates, and test reports for seals, and establish a dedicated technical file for key performance indicators.
IV. Operational Qualification (OQ)
Quantify core indicators and establish validated operating parameters for compliance.
OQ (Operational Qualification) is a critical testing phase focused on two core parameters: leak rate and sterilization validation. Conducted under standard, unloaded operating conditions, it involves comprehensive quantitative testing to establish the upper limits of the equipment's core performance and its range of regulatory compliance—making it a pivotal stage in the GMP validation process.
Specific Verification of Overall System Leakage Rate (Core Aspect of Sterile Barrier)
Leak rate is the baseline metric for sterility assurance in filling isolators, directly determining whether the Grade A clean environment remains under control. AN conducts comprehensive, multi-dimensional leak testing in strict accordance with ISO 13408-6 and YY/T 0567.6 standards, ensuring that all test data are quantifiable, verifiable, and traceable.
Q: Leak Testing of the Entire Enclosure
A: The test is conducted using the pressure decay method. The sealed enclosure of the isolator is pressurized to its standard operating pressure and held for a specified duration, during which the pressure decay is continuously monitored. Compliance criteria: The overall leak rate is strictly controlled at ≤0.5%/h—a standard far superior to basic industry requirements—ensuring the absence of both overt and covert leaks, and effectively preventing the ingress of external dust and microorganisms.
Q: Leak Testing of the Entire Enclosure
A: The test is conducted using the pressure decay method. The sealed enclosure of the isolator is pressurized to its standard operating pressure and held for a specified duration, during which the pressure decay is continuously monitored. Compliance criteria: The overall leak rate is strictly controlled at ≤0.5%/h—a standard far superior to basic industry requirements—ensuring the absence of both overt and covert leaks, and effectively preventing the ingress of external dust and microorganisms.
Q: Targeted Leak Testing for Critical Points
A: Focused testing is conducted on high-frequency interaction points and components prone to wear. This includes integrity testing for gloves and sleeves, leak testing for Rapid Transfer Ports (RTPs), inspection of access door seals, and checks for leaks at pipeline connections. Each individual glove is tested to ensure there are no punctures or pressure decay, guaranteeing a fully sealed barrier throughout all operator activities and material transfer processes.
Q: Leak Verification via Pressure Differential Interlock
A: This involves simulating positive-pressure production conditions and maintaining a stable positive-pressure gradient within the chamber. The test verifies whether any abnormal fluctuations in the pressure differential are caused by leaks, confirming that the equipment’s sealing system remains stable and compliant during dynamic operation.
Comprehensive VHP Sterilization Validation (Core of Aseptic Processing)
Sterilization validation is the cornerstone for preventing microbial contamination in products. It is far more than simply running a sterilization cycle; rather, it is a comprehensive, quantitative process that encompasses distribution validation, efficacy validation, residue validation, and the formalization of validated parameters—covering scenarios such as empty-chamber conditions, operational boundaries, and worst-case operating states.
Q: Verification of Sterilization Distribution Uniformity
A: To address "dead zones"—such as filling heads, needle holders, glove fingertips, chamber corners, the interior of transfer chambers, and the base of the equipment—hydrogen peroxide (VHP) concentration sensors and chemical indicators are placed at multiple strategic locations. The concentration and diffusion rate of the VHP gas are monitored throughout the entire sterilization cycle to ensure there are no "blind spots" and that sterilization is uniform across the entire chamber.
Q: Biological Efficacy Verification (BI Challenge)
A: Standardized Geobacillus stearothermophilus* biological indicators (BIs) are placed at all "worst-case" (most challenging) locations, followed by a full sterilization cycle. Compliance criteria: All BIs must show no microbial growth after the cycle, confirming that the sterilization process effectively eliminates microorganisms and meets the requirements for aseptic production.
Q: Validation of Sterilization Residues
A: Following the sterilization process, an aeration phase is initiated. Hydrogen peroxide residue levels within the chamber are monitored throughout this phase, ensuring a final concentration of ≤1 ppm. This eliminates the risk of chemical residues, thereby safeguarding both product quality and the safety of operating personnel.
Q: Standardization (Locking) of Sterilization Parameters
A: Through multiple rounds of gradient testing, optimal sterilization parameters—including concentration, saturation time, exposure time, aeration time, and temperature/humidity thresholds—are established and locked. These are incorporated into a standardized operating procedure (SOP) for sterilization, preventing sterilization failures that could otherwise arise from human error in parameter settings.
Supporting Environment and Functional Verification
The system simultaneously performs airflow visualization, filter integrity testing, monitoring of air velocity, pressure differential, temperature, humidity, and airborne particles. By incorporating two critical parameters—leakage and sterilization—it ensures a comprehensive, Grade A clean environment within the chamber. Furthermore, it validates interlock functions—such as those for abnormal pressure differentials, sterilization failures, and leakage alarms—to guarantee that equipment operation remains safe and under control.
V. Performance Qualification (PQ)
Verification under real-world operating conditions to confirm the stability of key performance indicators.
Once the OQ (Operational Qualification) phase is successfully completed under no-load conditions, the equipment must undergo PQ (Performance Qualification) under full-load, real-world operating conditions. This verifies that leakage rates and sterilization performance remain consistent and stable under actual production loads, with no degradation or deviation in key performance indicators.
✅ Full-load Leakage Rate Re-testing: With the equipment fully loaded—including all fixtures and materials—leakage tests are repeated for the entire unit and at critical points. This confirms that the arrangement of materials and the added load do not compromise the sealing integrity of the chamber, ensuring that the full-load leakage rate continues to meet the standard of ≤0.5%/h.
✅ Sterilization Efficacy Validation (Full-Load): Equipment and Biological Indicators (BIs) are positioned according to actual production loading patterns—accounting for potential obstructions and "dead zones"—and subjected to multiple sterilization cycles. This ensures that, even under complex, full-load conditions, there are no "blind spots" in sterilization and the required efficacy is fully maintained.
✅ Aseptic Process Simulation (APS) Validation: Three consecutive batches of media-fill simulations are conducted, incorporating all standard production interventions. With the core performance indicators met and no microbial growth observed—in full compliance with regulatory standards—this validates that the isolator’s sealing integrity and sterilization capabilities are robust enough to support routine aseptic production.
GMP validation is not a one-time event; factors such as leakage rates and sterilization performance may fluctuate due to component wear or changes in equipment operating conditions. Therefore, a full lifecycle management mechanism must be established.
During routine operation and maintenance, it is essential to strictly implement the following: glove leak testing for every shift, periodic spot checks for chamber leakage, regular filter integrity testing, verification of sterilization cycle parameters, and residue testing. Whenever components such as seals or gloves are replaced, sterilization parameters are adjusted, or major overhauls or equipment relocations occur, targeted re-testing of leakage rates and re-validation of sterilization processes must be conducted to ensure that key performance indicators consistently remain within compliant ranges. Furthermore, an annual review should be performed to consolidate operational data for these key indicators, thereby establishing a long-term compliance record.
Key Specifications and Validation Service Advantages for AN Filling Isolators
1. Quantifiable Compliance: Strict adherence to rigorous technical specifications—including a leak rate of ≤0.5%/h, VHP residue levels of ≤1ppm, and zero microbial growth in Biological Indicator (BI) tests—ensuring data that is quantifiable, verifiable, and traceable.
2. End-to-End Validation: Comprehensive testing of critical leak-rate and sterilization parameters throughout the entire lifecycle—from design, factory acceptance, and installation to operation, performance, and ongoing maintenance—leaving no gaps in the validation process.
3. Standardized Compliance Services: Full-scope technical support covering the entire qualification lifecycle (DQ/FAT/SAT/IQ/OQ/PQ). We provide specialized validation protocols, detailed test records, and comprehensive compliance reports for key parameters, helping enterprises successfully pass GMP inspections with greater efficiency.
The core of GMP compliance for filling isolators ultimately rests on two fundamental, consistently maintained capabilities: a hermetic, leak-free seal and sterilization with no "dead zones." Leveraging a full-lifecycle validation framework, AN implements rigorous, quantitative control over leak rates and key sterilization parameters. Through standardized, data-driven, and traceable validation processes, the company fortifies the essential safety baseline for sterile drug manufacturing, ensuring compliant production for pharmaceutical enterprises.
